United States · 
Who invested in Nivalis Therapeutics?
Nivalis Therapeutics's investors include RA Capital Management, Wellington Management, Deerfield, Rock Springs Capital and Jennison Associates, and 3 more on record.
2011201220132014
$10MSeries B$30MSeries BUnited States · Series B startup
Who invested in Nivalis Therapeutics
Funding summaryUpdated 26 Oct 2026
$40Mraised across 2 rounds since 2010, from 2 sources
$10MSeries B$30MSeries B
- Latest round
- Series B, $30MNov 2014
- Step-upi
- 3×
- Investors
- 8
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $10M Jul 2010
- Biggest round
- $30M Series B · Nov 2014
- Between rounds
- 4.3 years from the last two
The rounds
- Nov 2014Series B$30M5 new
From a historical funding record
- Jul 2010
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Sabby CapitalPrivate equity1round
Tiger Technology Global ManagementInvestment firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nivalis Therapeutics
How much has Nivalis Therapeutics raised?
Nivalis Therapeutics has raised $40M across 2 rounds since 2010.
When did Nivalis Therapeutics last raise?
Nivalis Therapeutics's most recent round was a Series B of $30M in Nov 2014.
What was Nivalis Therapeutics's biggest round?
Its most recent round, $30M in Nov 2014, is also its largest on record.
Who backed Nivalis Therapeutics first?
Nivalis Therapeutics's first round on record, in Jul 2010, was backed by Deerfield, Tiger Technology Global Management and Bridger Capital.
What stage is Nivalis Therapeutics at?
Nivalis Therapeutics's latest named round is a Series B, in Nov 2014.
Where is Nivalis Therapeutics based?
Nivalis Therapeutics is based in the United States.
Companies like Nivalis Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.